Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

    Risultato della ricerca: Articlepeer review

    Fingerprint

    Entra nei temi di ricerca di 'Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.'. Insieme formano una fingerprint unica.

    Medicine & Life Sciences